Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed) (c. 2377)

[F1 ANNEX III U.K. LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED

Textual Amendments

F1 Substituted by Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin.

1. Anti-infectious agents U.K.

1.1. Chemotheurapeutics U.K.

1.1.2. Benzenesulphonamides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Clorsulon	Clorsulon	Bovine	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			150 μg/kg	Liver
			400 μg/kg	Kidney

1.2. Antibiotics U.K.

1.2.1. Beta-lactamase inhibitors U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Clavulanic acid	Clavulanic acid	Bovine, ovine	200 μg/kg	Milk	[F2 Provisional MRLs expire on 1 July 2001]
		Bovine, ovine, porcine	200 μg/kg	Muscle
			200 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney

Textual Amendments

F2 Substituted by Commission Regulation (EC) No 1943/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

1.2.2. Macrolides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[F3 Acetylisovaleryltylosin	Sum of acetylisovaleryltylosin and 3-O-acetyltylosin	Porcine	100 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			100 μg/kg	Skin and fat
			100 μg/kg	Liver
			100 μg/kg	Kidney]
Erythromycin	MRLs apply to all microbiological active residues expressed as erythromycin equivalent	Bovine, ovine	40 μg/kg	Milk	Provisional MRLs expire on 1 June 2000
		Bovine, ovine, porcine, poultry	400 μg/kg	Muscle
			400 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney
		Poultry	200 μg/kg	Eggs
Josamycin	Josamycin	Chicken	200 μg/kg	Muscle	[F4 Provisional MRLs expire on 1.7.2002]
			200 μg/kg	Fat
			200 μg/kg	Liver
			400 μg/kg	Kidney
			200 μg/kg	Eggs
[F5	Sum of the microbiologically active metabolites, expressed as josamycin	Porcine	200 μg/kg	Muscle	Provisional MRLs expire on 1.7.2002
			200 μg/kg	Skin and fat
			200 μg/kg	Liver
			400 μg/kg	Kidney]
[F6 Tilmicosin	Tilmicosin	Bovine	40 μg/kg	Milk	Provisional MRLs expire on 1.1.2001]
[F7 Tulathromycin	(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2- ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa- 6-azacyclopent-decan-15-one expressed as tulathromycin equivalents	Bovine	100 μg/kg	Fat	Provisional MRLs expire on 1 July 2004 ; not for use in animals from which milk is produced for human consumption
			3 000  μg/kg	Liver
			3 000  μg/kg	Kidney
		Porcine	100 μg/kg	Skin and fat	Provisional MRLs expire on 1 July 2004
			3 000  μg/kg	Liver
			3 000  μg/kg	Kidney]

Textual Amendments

F3 Inserted by Commission Regulation (EC) No 1286/2000 of 19 June 2000 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F4 Substituted by Commission Regulation (EC) No 2338/2000 of 20 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F5 Inserted by Commission Regulation (EC) No 953/1999 of 5 May 1999 amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F6 Inserted by Commission Regulation (EC) No 2593/1999 of 8 December 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F7 Inserted by Commission Regulation (EC) No 1937/2002 of 30 October 2002 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F8 1.2.4. Cephalosporins U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cefacetrile	Cefacetrile	Bovine	125 μg/kg	Milk	[F9 Provisional MRLs expire on 1.1.2002] For intrammamary use only
[F10 Cefalonium	Cefalonium	Bovine	10 μg/kg	Milk	[F11 Provisional MRLs expire on 1.1.2003] ]
[F12 Cefoperazone	Cefoperazone	Bovine	50 μg/kg	Milk	Provisional MRLs expire on 1 January 2001]
[F13 Cefquinome	Cefquinome	Porcine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2000
			50 μg/kg	Skin + fat
			100 μg/kg	Liver
			200 μg/kg	Kidney]
Cephapirin	Sum of cephapirin and desacetylcephapirin	Bovine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			50 μg/kg	Liver
			100 μg/kg	Kidney
			10 μg/kg	Milk]

Textual Amendments

F9 Substituted by Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F10 Inserted by Commission Regulation (EC) No 2728/1999 of 20 December 1999 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F11 Substituted by Commission Regulation (EC) No 1322/2001 of 29 June 2001 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F12 Inserted by Commission Regulation (EC) No 1943/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F13 Inserted by Commission Regulation (EC) No 954/1999 of 5 May 1999 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

Textual Amendments

F8 Inserted by Commission Regulation (EC) No 804/1999 of 16 April 1999 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

1.2.5. Aminoglycosides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Aminosidine	Aminosidine	Bovine, porcine, rabbits, chicken	500 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
			1 500  μg/kg	Liver
			1 500  μg/kg	Kidney
Apramycin	Apramycin	Bovine	1 000  μg/kg	Muscle	Provisional MRLs expire on 1 July 1999
		For use in non-lactating cattle only	1 000  μg/kg	Fat
			10 000  μg/kg	Liver
			20 000  μg/kg	Kidney
		Porcine	1 000  μg/kg	Muscle
			1 000  μg/kg	Skin and fat
			1 000  μg/kg	Liver
			5 000  μg/kg	Kidney
[F14 Dihydrostreptomycin	Dihydrostreptomycin	Bovine, ovine	500 μg/kg	Muscle	Provisional MRLs expire on 1.6.2002
			500 μg/kg	Fat
			500 μg/kg	Liver
			1 000  μg/kg	Kidney
			200 μg/kg	Milk
		Porcine	500 μg/kg	Muscle
			500 μg/kg	Skin and fat
			500 μg/kg	Liver
			1 000  μg/kg	Kidney
Gentamicin	Gentamicin	Bovine	100 μg/kg	Milk	Provisional MRLs expire on 1.6.2002
		Bovine, porcine	50 μg/kg	Muscle
			50 μg/kg	Fat
			200 μg/kg	Liver
			750 μg/kg	Kidney]
[F15 Kanamycin	Kanamycin	Rabbits	100 μg/kg	Muscle	[F16 Provisional MRLs expire on 1.1.2004]
			100 μg/kg	Fat
			600 μg/kg	Liver
			2 500  μg/kg	Kidney
		Bovine, ovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			600 μg/kg	Liver
			2 500  μg/kg	Kidney
			150 μg/kg	Milk
		Porcine, chicken	100 μg/kg	Muscle
			100 μg/kg	Skin + fat
			600 μg/kg	Liver
			2 500  μg/kg	Kidney]
[F14 Neomycin (including framycetin)	Neomycin B	Bovine, porcine, chicken	500 μg/kg	Muscle	Provisional MRLs expire on 1.6.2002
			500 μg/kg	Fat
			500 μg/kg	Liver
			5 000  μg/kg	Kidney
		Bovine	500 μg/kg	Milk
		Chicken	500 μg/kg	Eggs]
Spectinomycin	Spectinomycin	Bovine	200 μg/kg	Milk	Provisional MRLs expire on 1 July 2000
		Bovine, porcine, poultry	300 μg/kg	Muscle
			500 μg/kg	Fat
			2 000  μg/kg	Liver
			5 000  μg/kg	Kidney
[F10		Ovine Not for use in animals from which milk is produced for human consumption	300 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			500 μg/kg	Fat
			2 000  μg/kg	Liver
			5 000  μg/kg	Kidney
		Chicken	200 μg/kg	Eggs]
[F14 Streptomycin	Streptomycin	Bovine, ovine	500 μg/kg	Muscle	Provisional MRLs expire on 1.6.2002
			500 μg/kg	Fat
			500 μg/kg	Liver
			1 000  μg/kg	Kidney
			200 μg/kg	Milk
		Porcine	500 μg/kg	Muscle
			500 μg/kg	Skin and fat
			500 μg/kg	Liver
			1 000  μg/kg	Kidney]

Textual Amendments

F14 Substituted by Commission Regulation (EC) No 1960/2000 of 15 September 2000 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F15 Inserted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F16 Substituted by Commission Regulation (EC) No 2162/2001 of 7 November 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

1.2.6. Quinolones U.K.

a [F17 Provisional MRLs expire 1 January 2006 .
b Not for use in animals from which milk is produced for human consumption.]
Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[F5 Danofloxacin	Danofloxacin	Porcine	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2000
			50 μg/kg	Skin and fat
			200 μg/kg	Liver
			200 μg/kg	Kidney]
Decoquinate	Decoquinate	Bovine, ovine	500 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
			500 μg/kg	Fat
			500 μg/kg	Liver
			500 μg/kg	Kidney
[F18 Difloxacin	Difloxacin	Bovine Not for use in animals from which milk is produced for human consumption	400 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			100 μg/kg	Fat
			1 400 μg/kg	Liver
			800 μg/kg	Kidney
		Porcine	400 μg/kg	Muscle
			100 μg/kg	Skin and fat
			800 μg/kg	Liver
			800 μg/kg	Kidney]
Enrofloxacin	Sum of enrofloxacin and ciprofloxacin	Ovine	100 μg/kg	Muscle	Provisional MRLs expire on 1 July 1999
			100 μg/kg	Fat
			300 μg/kg	Liver
			200 μg/kg	Kidney
Flumequine	Flumequine	Bovine, ovine, porcine, chicken	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			50 μg/kg	Fat or skin and fat
			100 μg/kg	Liver
			300 μg/kg	Kidney
		Salmonidae	150 μg/kg	Muscle and skin
Marbofloxacin	Marbofloxacin	Bovine	150 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
			50 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
			75 μg/kg	Milk
		Porcine	150 μg/kg	Muscle
			50 μg/kg	Skin and fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
[F8 [F19 Oxolinic acid a	Oxolinic acid	Bovine b	100 µg/kg	Muscle
			50 µg/kg	Fat
			150 µg/kg	Liver
			150 µg/kg	Kidney]
		Porcine	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
		Chicken	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			150 μg/kg	Liver
			150 μg/kg	Kidney
			50 μg/kg	Eggs
		Fin fish	300 μg/kg	Muscle and skin in natural proportions]

Textual Amendments

F17 Inserted by Commission Regulation (EC) No 546/2004 of 24 March 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F18 Inserted by Commission Regulation (EC) No 997/1999 of 11 May 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F19 Substituted by Commission Regulation (EC) No 546/2004 of 24 March 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

1.2.9. Polymyxins U.K.

Phamarcologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Colistin	Colistin	Bovine, ovine	50 μg/kg	Milk	[F4 Provisional MRLs expire on 1.7.2002]
		Bovine, ovine, porcine, chicken, rabbits	150 μg/kg	Muscle
			150 μg/kg	Fat
			150 μg/kg	Liver
			200 μg/kg	Kidney
		Chicken	300 μg/kg	Eggs

1.2.10. Penicillins U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[F8 Nafcillin	Nafcillin	Bovine	300 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney
			30 μg/kg	Milk]
Penethamate	Benzylpenicillin	Ovine	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			4 μg/kg	Milk
		Porcine	50 μg/kg	Muscle
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney

1.2.11. Florfenicol and related compounds U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Florfenicol	Sum of florfenicol and its metabolites measured as florfenicol-amine	Fish	1 000  μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 July 2001
[F8 Thiamphenicol	Thiamphenicol	Ovine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
		Porcine	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
		Fin fish	50 μg/kg	Muscle and skin in natural proportions]

[F5 1.2.12. Polypeptides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Bacitracin	Bacitracin	Bovine	150 μg/kg	Milk	Provisional MRLs expire on 1.7.2001]

[F8 1.2.13. Lincosamides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Lincomycin	Lincomycin	Ovine	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			500 μg/kg	Liver
			1 500 μg/kg	Kidney
			150 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			500 μg/kg	Liver
			1 500 μg/kg	Kidney
		Chicken	100 μg/kg	Muscle
			50 μg/kg	Skin + fat
			500 μg/kg	Liver
			1 500 μg/kg	Kidney
			50 μg/kg	Eggs
[F5 Pirlimycin	Pirlimycin	Bovine	100 μg/kg	Muscle	Provisional MRLs expire on 1.7.2000
			100 μg/kg	Fat
			1 000 μg/kg	Liver
			400 μg/kg	Kidney
			100 μg/kg	Milk] ]

[F10 1.2.14. Pleuromutilines U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Tiamulin	Sum of metabolites that may be hydrolysed to 8-a-hydroxymutilin	Turkey	100 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			100 μg/kg	Skin and fat
			300 μg/kg	Liver]

2. Antiparasitic agents U.K.

2.1. Agents acting against endoparasites U.K.

[F18 2.1.1. Phenol derivatives including salicylanides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Oxyclozanide	Oxyclozanide	Bovine	20 μg/kg	Muscle	[F4 Provisional MRLs expire on 1.7.2002]
			20 μg/kg	Fat
			500 μg/kg	Liver
			100 μg/kg	Kidney
			10 μg/kg	Milk
		Ovine	20 μg/kg	Muscle
			20 μg/kg	Fat
			500 μg/kg	Liver
			100 μg/kg	Kidney]

2.1.2. Benzimidazoles and pro-benzimidazoles U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Albendazole sulphoxide	Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole	Bovine, ovine	100 μg/kg	Milk	Provisional MRLs expire on 1 January 2000
		Bovine, ovine, pheasant	100 μg/kg	Muscle
			100 μg/kg	Fat
			1 000  μg/kg	Liver
			500 μg/kg	Kidney
[F10 Mebendazole	Sum of mebendazole methyl (5-(1-hidroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents	Ovine, caprine, equidae Not for use in animals from which milk is produced for human consumption	60 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			60 μg/kg	Fat
			400 μg/kg	Liver
			60 μg/kg	Kidney]
Netobimin	Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino- benzimidazole sulphone	Bovine, ovine, caprine	100 μg/kg	Muscle	Provisional MRLs expire on 31 July 1999
			100 μg/kg	Fat
			1 000  μg/kg	Liver
			500 μg/kg	Kidney
			100 μg/kg	Milk

[F18 2.1.3. Tetrahydropyrimides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Morantel	Sum of residues which may be hydrolysed to N-Methyl-1,3-propanediamine and expressed as morantel equivalents	Bovine, ovine	100 μg/kg	Muscle	[F11 Provisional MRLs expire on 1.7.2003]
			100 μg/kg	Fat
			800 μg/kg	Liver
			200 μg/kg	Kidney
			100 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			800 μg/kg	Liver
			200 μg/kg	Kidney]

[F6 2.1.5. Piperazine derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Piperazine	Piperazine	Porcine	400 μg/kg	Muscle	[F20 Provisional MRLs expire on 1.7.2003]
			800 μg/kg	Skin and fat
			2 000  μg/kg	Liver
			1 000  μg/kg	Kidney
		Chicken	2 000  μg/kg	Eggs]

Textual Amendments

F20 Substituted by Commission Regulation (EC) No 1478/2001 of 18 July 2001 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F10 2.1.6. Salicylanilides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Rafoxanide	Rafoxanide	Bovine Not for use in animals from which milk is produced for human consumption	30 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			30 μg/kg	Fat
			10 μg/kg	Liver
			40 μg/kg	Kidney
		Ovine Not for use in animals from which milk is produced for human consumption	100 μg/kg	Muscle
			250 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney]

2.2. Agents acting against ectoparasites U.K.

2.2.1. Formamidines U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Amitraz	Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz	Bees	200 μg/kg	Honey	Provisional MRLs expire on 1 July 1999

2.2.2. Iminophenyl thiazolidine derivative U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cymiazole	Cymiazole	Bees	1 000  μg/kg	Honey	[F21 Provisional MRLs expire on 1.7.2001]

Textual Amendments

F21 Substituted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

2.2.3. Pyretrin and pyrethroids U.K.

a [F22 Provisional MRLs expire on 1 July 2006 .]
Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cyfluthrin	Cyfluthrin	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1 January 2001
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
				Further provisions in Council Directive 94/29/EC are to be observed ( OJ L 189, 23.7.1994, p. 67 )
[F13 Alphacypermethrin	Cypermethrin (sum of isomers)	Bovine, ovine	20 μg/kg	Muscle	[F23 Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed]
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	Milk [F24 Further provisions in Council Directive 93/57/EC ( OJ L 211, 23.8.1992, p. 1 ) are to be observed]
		Chicken	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Eggs
[F23 Cypermethrin	Cypermethrin (sum of isomers)	Bovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	Milk
	Cypermethrin (sum of isomers)	Ovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003 Not for use in animals from which milk is produced for human consumption
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney]
		Porcine	20 μg/kg	Muscle
			200 μg/kg	Skin + fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
		Chicken	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Eggs
		Salmonidae	50 μg/kg	Muscle and skin in natural proportions	[F25 Provisional MRLs expire on 1.7.2003] ]
[F26 Deltamethrin	Deltamethrin	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1 July 2001
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
		Ovine Not for use in animals from which milk is produced for human consumption	10 μg/kg	Muscle
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
		Chicken	10 μg/kg	Muscle	[F27 Provisional MRLs expire on 1.7.2003]
			50 μg/kg	Skin + fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			50 μg/kg	Eggs
[F28		Fin fish	10 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1.1.2002] ]
[F29 Fenvalerate a	Fenvalerate (sum of RR, SS, RS and SR isomers)	Bovine	25 μg/kg	Muscle
			250 μg/kg	Fat
			25 μg/kg	Liver
			25 μg/kg	Kidney
			40 μg/kg	Milk]
[F9 Permethrin	Permethrin (sum of isomers)	Chicken, porcine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2003
			500 μg/kg	Skin and fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
		Bovine, caprine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2003
			500 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Milk	Further provisions in Commission Directive 98/82/EC are to be observed ( OJ L 290, 29.10.1998, p. 25 )
		Chicken	50 μg/kg	Eggs	Provisional MRLs expire on 1.1.2003]

Textual Amendments

F22 Inserted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).

F23 Substituted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F24 Deleted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F25 Inserted by Commission Regulation (EC) No 77/2002 of 17 January 2002 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F26 Inserted by Commission Regulation (EC) No 1942/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F27 Inserted by Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F28 Inserted by Commission Regulation (EC) No 1960/2000 of 15 September 2000 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F29 Substituted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).

2.2.4. Organophosphates U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Azamethiphos	Azamethiphos	Salmonidae	100 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 June 1999
[F15 Coumafos	Coumafos	Bees	100 μg/kg	Honey	Provisional MRLs expire on 1.7.2001]
[F30 Phoxim	Phoxim	Porcine	20 μg/kg	Muscle	Provisional MRLs expire on 1 January 2001
			700 μg/kg	Skin and fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
		[F31 Ovine	50 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001 ; not for use in animals from which milk is produced for human consumption
			400 μg/kg	Fat
			50 μg/kg	Kidney]
		[F32 Chicken	50 μg/kg	Muscle	Provisional MRLs expire on 1.7.2005 .
			550 μg/kg	Skin and fat
			25 μg/kg	Liver
			50 μg/kg	Kidney
			60 μg/kg	Eggs] ]
[F10 Propetamphos	Sum of residues of propetamphos and desisopropyl-propetamphos	Ovine Not for use in animals from which milk is produced for human consumption	90 μg/kg	Fat	Provisional MRLs expire on 1.1.2001
			90 μg/kg	Kidney]

Textual Amendments

F30 Inserted by Commission Regulation (EC) No 2385/1999 of 10 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F31 Inserted by Commission Regulation (EC) No 2391/2000 of 27 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F32 Inserted by Commission Regulation (EC) No 2011/2003 of 14 November 2003 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

2.2.5. Acyl urea derivates U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Teflubenzuron	Teflubenzuron	Salmonidae	500 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 July 1999
[F18 Diflubenzuron	Diflubenzuron	Salmonidae	1 000 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1.7.2000]

[F33 2.2.6. Pyrimidines derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Dicyclanil	Sum of dicyclanil and 2,4,6-triamino-pyrimidine-5-carbonitrile	Ovine	200 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000 ; Not for use in animals from which milk is produced for human consumption
			50 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney]

Textual Amendments

F33 Inserted by Commission Regulation (EC) No 2393/1999 of 11 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F6 2.2.7. Triazine derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cyromazine	Cyromazine	Ovine	300 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001 Not for use in animals from which milk is produced for human consumption
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney]

2.3. Agents acting against endo- and ectoparasites U.K.

2.3.1. Avermectins U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[F10 Abamectin	Avermectin B1a	Ovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			25 μg/kg	Liver
			20 μg/kg	Kidney
Doramectin	Doramectin	Deer, inclusing reindeer	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			100 μg/kg	Fat
			50 μg/kg	Liver
			30 μg/kg	Kidney]
Moxidectin	Moxidectin	Equidae	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			500 μg/kg	Fat
			100 μg/kg	Liver
			50 μg/kg	Kidney

[F5 2.4. Agents acting against protozoa U.K.

2.4.1. Carbanilides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Imidocarb	Imidocarb	Bovine, ovine	300 μg/kg	Muscle	Provisonal MRLs expire on 1.1.2002
			50 μg/kg	Fat
			2 000 μg/kg	Liver
			1 500 μg/kg	Kidney
			50 μg/kg	Milk

[F18 2.4.2. Quinazolone derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Halofuginone	Halofuginone	Bovine	10 μg/kg	Muscle	Provisional MRL's expire on 1.1.2001
			25 μg/kg	Fat
			30 μg/kg	Liver
			30 μg/kg	Kidney]

[F6 2.4.3. Triazinetrione derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Toltrazuril	Toltrazuril sulfone	Porcine	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			150 μg/kg	Skin and fat
			500 μg/kg	Liver
			250 μg/kg	Kidney]

[F34 2.4.4. Other anti-protozoal agents U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRL	Target tissues	Other provisions
Amprolium	Amprolium	Chicken, turkey	200 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			200 μg/kg	Skin and fat
			200 μg/kg	Liver
			400 μg/kg	Kidney
			1 000  μg/kg	Eggs] ]

Textual Amendments

F34 Inserted by Commission Regulation (EC) No 1295/2000 of 20 June 2000 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

3. Agents acting on the nervous system U.K.

3.2. Agents acting on the autonomic nervous system U.K.

3.2.1. β 2 sympathomimetic agents U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Clenbuterol hydrochloride	Clenbuterol	Bovine	0,1 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000
		Indication: solely for tocolysis in parturient cows	0,5 μg/kg	Liver
			0,5 μg/kg	Kidney
			0,05 μg/kg	Milk
		Equidae	0,1 μg/kg	Muscle
		Indications: tocolysis and the treatment of respiratory ailments	0,5 μg/kg	Liver
			0,5 μg/kg	Kidney

[F5 3.2.2. Anti-adrenergics U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Carazolol	Carazolol	Bovine	5 μg/kg	Muscle	Provisional MRLs expire on 1.1.2000
			5 μg/kg	Fat
			15 μg/kg	Liver
			15 μg/kg	Kidney
			1 μg/kg	Milk]

5. Anti-inflammatory agents U.K.

5.1. Nonsteroidal anti-inflammatory agents U.K.

5.1.1. Arylpropionic acid derivative U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Carprofen	Carprofen	Bovine	500 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			500 μg/kg	Fat
			1 000  μg/kg	Liver
			1 000  μg/kg	Kidney
		Equidae	50 μg/kg	Muscle
			100 μg/kg	Fat
			1 000  μg/kg	Liver
			1 000  μg/kg	Kidney

5.1.2. Enolic acid derivates U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Meloxicam	Meloxicam	Bovine	25 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			60 μg/kg	Liver
			35 μg/kg	Kidney

[F10 5.1.3. Pyrazolone derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[F11 Metamizole	4-Methylaminoantipyrin	Bovine, porcine, equidae	200 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003 . Not for use in animals from which milk is produced for human consumption
			200 μg/kg	Fat
			200 μg/kg	Liver
			200 μg/kg	Kidney] ]

[F35 6. Agents acting on the reproductive system U.K.

6.1. Progestogens U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Altrenogest	Altrenogest	Porcine	3 μg/kg	[F36 Skin and fat]	[F36 Provisional MRLs expire on 1.1.2005 ; for zootechnical use only]
			3 μg/kg	Liver
			3 μg/kg	Kidney
		Equidae	3 μg/kg	Fat
			3 μg/kg	Liver
			3 μg/kg	Kidney
[F37 Flugestone acetate	Flugestone acetate	Ovine, caprine	0,5 μg/kg	Muscle	Provisional MRLs expire on 1.1.2008 ; for therapeutic or zootechnical use only
			0,5 μg/kg	Fat
			0,5 μg/kg	Liver
			0,5 μg/kg	Kidney
Norgestomet	Norgestomet	Bovine	0,5 μg/kg	Muscle	Provisional MRLs expire on 1.1.2008 ; for therapeutic or zootechnical use only
			0,5 μg/kg	Fat
			0,5 μg/kg	Liver
			0,5 μg/kg	Kidney
			0,15 μg/kg	Milk] ]

Textual Amendments

F36 Substituted by Commission Regulation (EC) No 1530/2002 of 27 August 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F37 Substituted by Commission Regulation (EC) No 665/2003 of 11 April 2003 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

Textual Amendments

F35 Inserted by Council Regulation (EC) No 2584/2001 of19 December 2001 amending Annexes I and III of Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F3 7. Corticoids U.K.

7.1. Glucocorticoids U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Methylprednisolone	Methylprednisolone	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001 . Not for use in animals from which milk is produced for human consumption
			10 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney] ]